Yantai Dongcheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Yantai Dongcheng Pharmaceutical Co Ltd cash flow-to-debt ratio. Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of CN¥239.54 Million could theoretically repay 0% of its total liabilities (CN¥3.61 Billion) in one year. Check 002675 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Cash flow-to-debt ratio of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. Historical debt coverage capacity for Yantai Dongcheng Pharmaceutical Co Ltd across 18 annual periods. Check Yantai Dongcheng Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Yantai Dongcheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Yantai Dongcheng Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Yantai Dongcheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002675 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥584.61 Million | CN¥3.61 Billion | ▲ +84.2% |
| 2024 | 0.09x | CN¥287.15 Million | CN¥3.26 Billion | ▼ -14.6% |
| 2023 | 0.10x | CN¥276.94 Million | CN¥2.69 Billion | ▼ -70.1% |
| 2022 | 0.34x | CN¥996.54 Million | CN¥2.89 Billion | ▼ -4.0% |
| 2021 | 0.36x | CN¥943.58 Million | CN¥2.63 Billion | ▲ +52.0% |
| 2020 | 0.24x | CN¥572.58 Million | CN¥2.43 Billion | ▼ -14.8% |
| 2019 | 0.28x | CN¥696.38 Million | CN¥2.52 Billion | ▲ +32.3% |
| 2018 | 0.21x | CN¥493.06 Million | CN¥2.36 Billion | ▲ +98.7% |
| 2017 | 0.11x | CN¥208.94 Million | CN¥1.98 Billion | ▼ -36.5% |
| 2016 | 0.17x | CN¥196.28 Million | CN¥1.18 Billion | ▼ -22.5% |
| 2015 | 0.21x | CN¥66.69 Million | CN¥311.94 Million | ▼ -14.1% |
| 2014 | 0.25x | CN¥52.00 Million | CN¥209.06 Million | ▲ +253.5% |
| 2013 | -0.16x | CN¥-20.60 Million | CN¥127.18 Million | ▼ -126.5% |
| 2012 | 0.61x | CN¥44.53 Million | CN¥72.84 Million | ▼ -35.3% |
| 2011 | 0.95x | CN¥138.83 Million | CN¥146.82 Million | ▲ +178.8% |
| 2010 | 0.34x | CN¥57.02 Million | CN¥168.14 Million | ▲ +261.3% |
| 2009 | -0.21x | CN¥-26.60 Million | CN¥126.53 Million | ▼ -158.5% |
| 2008 | 0.36x | CN¥41.57 Million | CN¥115.74 Million | — |